InMed Pharmaceuticals Inc. (INM) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    InMed Pharmaceuticals Inc...

    NASDAQ: INM · Real-Time Price · USD
    2.16
    0.00 (0.00%)
    At close: Sep 12, 2025, 3:19 PM

    InMed Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Net Income
    		 -7.68M -7.95M -18.6M -10.2M
    Depreciation & Amortization
    		 604.52K 596K 511.79K 120.87K
    Stock-Based Compensation
    		 137.71K 278.15K 697.89K 610.19K
    Other Working Capital
    		 -435.56K 16.17K -687.51K -490.65K
    Other Non-Cash Items
    		 316.82K -803 4.46M 374.23K
    Deferred Income Tax
    		 n/a 356.89K n/a -242.39K
    Change in Working Capital
    		 -369.34K -565.82K -2.73M -450.45K
    Operating Cash Flow
    		 -6.99M -7.28M -15.58M -9.79M
    Capital Expenditures
    		 -9.29K -161.8K -39.11K -1.73K
    Cash Acquisitions
    		 n/a -500K -208.89K n/a
    Purchase of Investments
    		 -42.08K -42.27K -425K n/a
    Sales Maturities Of Investments
    		 42.08K 42.27K 425K n/a
    Other Investing Acitivies
    		 -9.29K -501.79K -425K 0.00
    Investing Cash Flow
    		 -9.29K -661.8K -673K -1.73K
    Debt Repayment
    		 n/a n/a -290.83K n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 646.00 -1.78M -1.62M
    Financial Cash Flow
    		 4.65M 10.68M 15.07M 10.85M
    Net Cash Flow
    		 -2.34M 2.74M -1.19M 1.56M
    Free Cash Flow
    		 -7M -7.45M -15.62M -9.79M

    Add to Watchlist